TNF-induced IL-8 and MCP-1 production in the eosinophilic cell line, EOL-1

The role of eosinophils in inflammation and their mode of activation is not well understood. Eosinophil accumulation and subsequent expression of cytokines at the site of inflammation may play a role in exacerbation of inflammatory responses. In the present study, we have examined the role of TNF-α in eosinophil activation and chemokine production using a human leukaemic eosinophil cell line, EOL-1. Initial studies demonstrated that TNF-α induced the upregulation of IL-8 and MCP-1 mRNA and protein. Kinetic studies indicated production of chemokines, IL-8 and MCP-1, as early as 4 h post-activation, with peak levels of chemokine produced at 8 h, and decreasing by 24 h post-TNF-α activation. When IL-10, a suppressive cytokine, was incubated with TNF-α and EOL-1 cells, no effect was observed on IL-8 and MCP-1 production. However, dexamethasone, a glucocorticoid, demonstrated potent inhibitory effects on the EOL-1-derived chemokines. These studies indicate that eosinophils may be a significant source of chemokines capable of participating in, and maintaining, leukocyte recruitment during inflammatory responses, such as asthma.

[1]  H. Kita,et al.  Eosinophil major basic protein induces degranulation and IL-8 production by human eosinophils. , 1995, Journal of immunology.

[2]  S. Phan,et al.  Lung monocyte chemoattractant protein-1 gene expression in bleomycin-induced pulmonary fibrosis. , 1994, Journal of immunology.

[3]  R. Strieter,et al.  The Role of Interleukin‐8 in the Infectious Process a , 1994, Annals of the New York Academy of Sciences.

[4]  A. Wardlaw.  Eosinophils in the 1990s: new perspectives on their role in health and disease. , 1994, Postgraduate medical journal.

[5]  R. Whyte,et al.  Production of interleukin-10 by human bronchogenic carcinoma. , 1994, The American journal of pathology.

[6]  T. Springer,et al.  Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[7]  M. Burdick,et al.  Regulation of neutrophil-derived chemokine expression by IL-10. , 1994, Journal of immunology.

[8]  J. Shute,et al.  Interleukin‐8 is a potent eosinophil chemo‐attractant , 1994, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[9]  T. Standiford,et al.  The immunopathology of chemotactic cytokines: the role of interleukin-8 and monocyte chemoattractant protein-1. , 1994, The Journal of laboratory and clinical medicine.

[10]  L. Koenderman,et al.  Upregulation of formyl-peptide and interleukin-8-induced eosinophil chemotaxis in patients with allergic asthma. , 1993, The Journal of allergy and clinical immunology.

[11]  R. Strieter,et al.  The immunopathology of chemotactic cytokines. , 1993, Advances in experimental medicine and biology.

[12]  Y. Vodovotz,et al.  Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-beta and interleukin-10. , 1992, The Journal of biological chemistry.

[13]  F. S. Becker,et al.  Cytokine-induced neutrophil-derived interleukin-8. , 1992, The American journal of pathology.

[14]  T. Fukuda,et al.  Airway hyperresponsiveness, increased intracellular spaces of bronchial epithelium, and increased infiltration of eosinophils and lymphocytes in bronchial mucosa in asthma. , 1992, The American review of respiratory disease.

[15]  H. Smith.  Asthma, inflammation, eosinophils and bronchial hyperresponsiveness , 1992, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[16]  L. Lin,et al.  IL-10, T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor. , 1992, Journal of immunology.

[17]  T. Mosmann,et al.  IL-10 inhibits cytokine production by activated macrophages. , 1991, Journal of immunology.

[18]  C G Figdor,et al.  Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes , 1991, The Journal of experimental medicine.

[19]  S. Durham,et al.  TNF alpha mRNA expression in allergic inflammation. , 1991, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[20]  T. Standiford,et al.  Interleukin-8 gene expression by a pulmonary epithelial cell line. A model for cytokine networks in the lung. , 1990, The Journal of clinical investigation.

[21]  R. Strieter,et al.  Cytokine networking in lung inflammation. , 1990, Hospital practice.

[22]  R. Strieter,et al.  Tumor Necrosis Factor–Alpha Gene Expression in Human Whole Blood , 1990, Journal of leukocyte biology.

[23]  E. Leonard,et al.  Leukocyte specificity and binding of human neutrophil attractant/activation protein-1. , 1990, Journal of immunology.

[24]  M. Baggiolini,et al.  Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. , 1989, The Journal of clinical investigation.

[25]  J. Westwick,et al.  Novel neutrophil-stimulating peptides. , 1989, Immunology today.

[26]  E. Appella,et al.  The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. , 1989, Science.

[27]  G. Hunninghake,et al.  Bronchoalveolar lavage of allergic asthmatic patients following allergen bronchoprovocation. , 1986, Chest.

[28]  S. Durham,et al.  Eosinophils, bronchial hyperreactivity and late‐phase asthmatic reactions , 1985, Clinical allergy.

[29]  T. Moore,et al.  Mediators of inflammation. , 1985, Seminars in arthritis and rheumatism.

[30]  H. Sluiter,et al.  Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. , 1985, The American review of respiratory disease.

[31]  G. Mathé,et al.  Establishment and characterization of a new human eosinophilic leukemia cell line. , 1985, Blood.